Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
testosterone propionate + testosterone enanthate
- Development stage
- Unknown
- Lead developer
- Bayer
- Modality
- Small Molecules
- Administration
- Intramuscular
01
Overview
Testoviron Depot is an oil-based injectable formulation containing a combination of two testosterone esters: testosterone propionate and testosterone enanthate. Manufactured by Bayer, it acts as an androgen receptor agonist. Upon intramuscular administration, the esters are hydrolyzed to release testosterone, which then binds to androgen receptors to drive the development of masculine sex organs and secondary sexual characteristics. It is indicated for male hypogonadism, delayed puberty in boys, and breast carcinoma in women. The formulation produces a depot effect, with testosterone levels peaking shortly after injection and gradually declining until the next dose. It is currently being evaluated in a multicenter randomized Phase 2 trial in Sweden for pubertal replacement therapy in boys with absent or delayed puberty.
- Brand names
- Testoviron Depot
- Other names
- TP/TEtestosterone propionate/enanthate
02
Targets
AR (Adrenergic receptors)
Beyond the preview
Go deeper on testosterone propionate + testosterone enanthate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on testosterone propionate + testosterone enanthate.